What the source reports
Exit argued that the concession restricted the public side’s room for manoeuvre and limited the company’s responsibility.
Reading the original source
Exit reported that the concession began with a 2.4-lek stamp price, later rose to 6 lek and faced a proposed shift to 2.4% of a medicine’s sale price. The outlet alleged this would sharply increase guaranteed revenue; the government’s stated justification was improved security.
Context and scope
These are criticisms of the agreement’s terms. The review does not present the report as a criminal judgment against SICPA.
Sources & supporting documents
This English digest is based on the original reporting or official material linked above and does not reproduce the full source.

